Record Setting Temperatures in the Setting of SARS-CoV-2 Suggests Dexmedetomidine Drug-Induced Fever: A Case Report.
J Investig Med High Impact Case Rep
; 12: 23247096241260959, 2024.
Article
en En
| MEDLINE
| ID: mdl-38869108
ABSTRACT
Patients infected with COVID-19 can develop coinfections or acute respiratory disorder that result in ventilation. Dexmedetomidine is a common medication used to sedate ventilated patients in the intensive care unit and for nonintubated patients prior to a surgical procedure. As a highly selective alpha-2 agonist, dexmedetomidine provides sedation while reducing the need for anxiolytics or opioids. However, previous case reports suggest dexmedetomidine can induce fever in a variety of conditions. The purpose of this case report is to describe a patient who acquired a fever of 42.6°C in the setting of COVID-19 after administration of dexmedetomidine.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Dexmedetomidina
/
Fiebre
/
SARS-CoV-2
/
COVID-19
/
Hipnóticos y Sedantes
Límite:
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
J Investig Med High Impact Case Rep
Año:
2024
Tipo del documento:
Article
País de afiliación:
Estados Unidos